Nursing Care for Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Case Study
Article Sidebar
Main Article Content
Abstract
Multisystem inflammatory syndrome in children is a complication associated with COVID-19 after the child has recovered. It is a serious condition that can be fatal. This syndrome has been found to affect males more frequently than females, with an average age of 9.7 years. Multisystem inflammatory syndrome in children may manifest during the recovery phase or emerge 4-6 weeks after a COVID-19 infection. Thailand introduced guidelines for diagnosing and treating multisystem inflammatory syndrome in children associated with COVID-19. These guidelines have led to rapid diagnosis and treatment, resulting in positive outcomes for patients. However, as multisystem inflammatory syndrome in children associated with COVID-19 is an emerging disease, nurses need to develop knowledge and skills that are consistent with the diagnosis and treatment guidelines. This is crucial for providing standardized nursing care. The purpose of this article is to provide knowledge and guidelines for planning nursing care for pediatric patients with multisystem inflammatory syndrome associated with COVID-19. The article aims to serve as a guideline for nurses, enabling them to deliver evidence-based nursing care that ensures patient safety and a good quality of life.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความและรายงานวิจัยในวารสารพยาบาลกระทรวงสาธารณสุข เป็นความคิดเห็นของ ผู้เขียน มิใช่ของคณะผู้จัดทำ และมิใช่ความรับผิดชอบของสมาคมศิษย์เก่าพยาบาลกระทรวงสาธารณสุข ซึ่งสามารถนำไปอ้างอิงได้
References
Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 2021; 325(11):1074-87.
World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. [internet]. 2020[cited 5 May 2023]. Available from: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescentswith-covid19.
Centers for Disease Control and Prevention Health Alert Network (HAN). Multisystem inflammatory syndrome in children (MIS-C) associated with Coronavirus disease 2019 (COVID 19) [internet]. 2020[cited 5 May2023]. Available from: https://emergency.cdc.gov/han/2020/han00432.asp.
Royal College of Pediatrics and Child Health. Guidance pediatrics multisystem inflammatory syndrome http://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Pediatric-multisystem inflammatory syndrome-20200501.pdf.
Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. J Infect Public Health 2020;13(12):1791-6.
Department of Disease Control. Corona virus disease (COVID-19). [internet]. 2023[cited 2023 May 31]. Available from: https://ddc.moph.go.th/viralpneumonia/eng/index.php.
Hfocus. Thai children in MIS-C associated COVID-19. [internet]. 2021[cited 31 May 2023]. Available from: https://www.hfocus.org/content/2021/10/23288.(in Thai)
Pediatric Infectious disease society of Thailand. Guidelines for diagnosis and treatment for multisystem inflammatory syndrome in children; MIS-C and hyperinflammation in pediatric COVID-19 in Thailand, Issue (revised edition) dated 30 November 2022. [internet]. 2022[cited 31 May 2023]. Available from: https://www.pidst.or.th/A1161.html
Hjelmgren H, Andersson K, Widegren J, Bergman E, Verme A, Mordrup K, et al. Multi-inflammatory syndrome in children (MIS-C) associated with COVID-19: a nursing perspective experience report from a high-income tertiary paediatric hospital context. Pediatric Rheumatology 2023;21:5.
Evans C, Davies P. SARS-CoV-2 paediatric inflammatory syndrome. Paediatr Child Health (Oxford). 2021;31(3):110-5.
Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 2020;369:m2094.
Pouletty M, Borocco C, Ouldali N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicenter cohort. Ann Rheum Dis 2020;217960.
Belhadjer Z, Mé ot M, Bajolle F, et al. (2020). Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 2020;10.1161/CIRCULATIONAHA.120.048360.
Cattalini M, Taddio A, Bracaglia C, Cimaz R, Paolera SD, Filocamo G, et al. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the rheumatology study group of the Italian society of pediatrics. Ital J Pediatr 2021;47(1):24.
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. Clinical guidance for multisystem inflammatory syndrome in children associated With SARSCoV-2 and hyperinflammation in pediatric COVID-19: Version 3. Arthritis Rheumatol 2022;74(4):e1-e20.
Cole LD, Osborne CM, Silveira LJ, Rao S, Lockwood JM, Kunkel MJ, et al. IVIG Compared to IVIG Plus Infliximab in multisystem inflammatory syndrome in children. Pediatrics 2021;e2021052702.doi: 10.1542/peds.2021-052702.
Brisca G, Consolaro A, Caorsi R, Pirlo D, Tuo G, Campanello C, et al. Timely recognition and early multi-step anti-inflammatory therapy may prevent ICU admission of patients with MIS-C: proposal for a severity score. Front Pediatr 2021;9:783745.
Pongsri P. Nursing care for multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19: Case study. Region 3 Medical and Public Health Journal 2023;20(1):44-50.(in Thai)
Riberiro SP, Boettcher S. Multisystem inflammatory syndrome in children associated with COVID-19: nursing care. Health Sciences Journal 2021;11(2):10-17.
Herdman TH, Kamitsuru S. Nursing diagnoses definitions and classification 2018–2020 the1 1th Edition. [internet]. 2020[ cited 6 June 2023]. Available: https://web.thieme.com/images/emails/NANDA_Preview.pdf.